Maurie Markman MD
Gynecologic Cancer
Professor of Medical Oncology City of Hope Comprehensive Cancer Center
Join to View Full Profile
1425 Stocton RoadJenkintown, PA 19046
Dr. Markman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1974 - 1978- New York University School of MedicineClass of 1974
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2002 - Present
PA State Medical License 2001 - 2026
GA State Medical License 2012 - 2015
TX State Medical License 2006 - 2012
MI State Medical License 2002 - 2006
OH State Medical License 1992 - 2006
IL State Medical License 2002 - 2005
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2011
Clinical Trials
- S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission Start of enrollment: 1997 Nov 01
- Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum Start of enrollment: 1997 Sep 01
- Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsWhat proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors i...Omali Pitiyarachchi, Michael Friedlander, James J Java, John K Chan, Deborah K Armstrong
Gynecologic Oncology. 2022-09-01 - 20 citationsDifferences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.Katherine Fuh, James J. Java, John K. Chan, Daniel S. Kapp, Bradley J. Monk
Gynecologic Oncology. 2019-08-01 - 9 citationsPharmaceutical Management of Ovarian Cancer: Current Status.Maurie Markman
Drugs. 2019-07-01
Other
- Intraperitoneal chemotherapy for treatment of ovarian cancerMarkman M, Walker JL
http://www.uptodate.com/contents/intraperitoneal-chemotherapy-for-treatment-of-ovarian-cancer
UpToDate, Wolters Kluwer Health - 2012-06-14
Press Mentions
Real-World Data Highlight Gaps in HER2+ Metastatic Breast Cancer TherapyAugust 20th, 2025- Q&A: Cervical CancerAugust 19th, 2025
- Q&A: Endometrial CancerAugust 13th, 2025
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
